Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci.
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsStructural and Functional Properties of Staphylococcal Superantigen-Like Protein 4Staphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environmentsPseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infectionIdentification of genetic determinants and enzymes involved with the amidation of glutamic acid residues in the peptidoglycan of Staphylococcus aureusTwo lytic transglycosylases in Neisseria gonorrhoeae impart resistance to killing by lysozyme and human neutrophils.Differential regulation of staphylococcal virulence by the sensor kinase SaeS in response to neutrophil-derived stimuli.The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion.The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses.High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae.Tuning the properties of the bacterial membrane with aminoacylated phosphatidylglycerol.The extracytoplasmic function sigma factor SigV plays a key role in the original model of lysozyme resistance and virulence of Enterococcus faecalisMembrane damage elicits an immunomodulatory program in Staphylococcus aureusRegulatory adaptation of Staphylococcus aureus during nasal colonization of humans.Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation.Clostridium difficile extracytoplasmic function σ factor σV regulates lysozyme resistance and is necessary for pathogenesis in the hamster model of infection.Staphylococcus epidermidis strategies to avoid killing by human neutrophilsContribution of peptidoglycan amidation to beta-lactam and lysozyme resistance in different genetic lineages of Staphylococcus aureus.Exploring innate glycopeptide resistance mechanisms in Staphylococcus aureusPeptidoglycan crosslinking relaxation plays an important role in Staphylococcus aureus WalKR-dependent cell viability.Structure of the Neisseria Adhesin Complex Protein (ACP) and its role as a novel lysozyme inhibitor.Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathwaysLysozyme resistance in Streptococcus suis is highly variable and multifactorial.Low levels of β-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureusD-alanylation of lipoteichoic acids confers resistance to cationic peptides in group B streptococcus by increasing the cell wall densityAntimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria.Mutations of the Listeria monocytogenes peptidoglycan N-deacetylase and O-acetylase result in enhanced lysozyme sensitivity, bacteriolysis, and hyperinduction of innate immune pathways.NsaRS is a cell-envelope-stress-sensing two-component system of Staphylococcus aureus.Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by phagolysosomal but not extracellular trap-associated cathelicidin.Posttranslocation chaperone PrsA2 regulates the maturation and secretion of Listeria monocytogenes proprotein virulence factorsThe Bacillus subtilis extracytoplasmic function σ factor σ(V) is induced by lysozyme and provides resistance to lysozyme.Bacillus subtilis σ(V) confers lysozyme resistance by activation of two cell wall modification pathways, peptidoglycan O-acetylation and D-alanylation of teichoic acidsStaphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner.The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides.GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus.The Anti-sigma Factor RsiV Is a Bacterial Receptor for Lysozyme: Co-crystal Structure Determination and Demonstration That Binding of Lysozyme to RsiV Is Required for σV ActivationRegulation of bacterial virulence gene expression by cell envelope stress responses.Staphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response.D-alanylation of lipoteichoic acid contributes to the virulence of Streptococcus suis.
P2860
Q24646677-5827EF53-4DEA-40EE-92BC-BDB428C52380Q27672113-7236BDFC-2EEE-4C02-864B-BD65131639B2Q28087340-FB20C751-B61B-4DCB-BA15-47F6C5FF4C8DQ28472320-5B1C2FA5-2881-45F1-BDCD-4E5E783EA718Q28480413-C7127B6B-1594-44F2-A702-4A787F9ED816Q30275502-AB134F3E-425F-477A-B045-B3DCE35C7FDDQ30361924-0F47F5FC-1259-496C-A216-83A757698EBEQ30886130-85BCB589-3A34-4C83-8994-9CE13487E7AAQ33339694-AFDE7DC9-4851-46C0-AB21-E9B518AF83A9Q33384565-D849EAE0-A142-4449-8414-AE48831D0833Q33392682-EE3FB5F2-9EF0-4F8E-8F40-D777F77D5005Q33507347-54C4F279-BB6D-45C1-BB08-1C8530599D7DQ33542993-AC55FD9A-E99B-4E4D-B0FD-C93671BC0D10Q33543122-BECA50AA-826A-4ADB-9698-94ECCC7F9D51Q33553375-3543651C-D033-42C2-984F-CCFF5A7268DEQ33564128-C457DFAD-167F-4C4A-8521-1DABFEFD54EEQ33603104-8CA7DF44-F9A8-4DCC-8095-98898C610302Q33719408-24D0322A-8874-46DE-B223-53DAF0FBBC94Q33730107-DA183D0B-4D54-4664-B440-E5A060E82E8AQ33762805-4875D2E9-47EB-4CA2-A2F7-6B658878B944Q33840892-EAA4C806-AE14-4113-9975-DF436F5C36CFQ33898758-5772FC8E-B8AD-4CE6-B126-DB68D29A395EQ33963770-168FC9F7-73EC-466D-94D3-DEDDEFA1E82CQ34257398-9290280E-1A4A-49E6-A754-4EBF1C039901Q34291700-9F6AD03F-0E78-41EF-B577-41E6535407B0Q34411837-17454687-C877-412D-80AD-9F605C34C93AQ34549813-86F14D91-E6B5-4E0C-A4A6-45392FC16710Q35191858-DD599E09-16C1-4AFB-9FBA-244DD48CFBB2Q35199089-E862E817-1EAF-48C8-A5B3-E31FA1ABD8C8Q35329635-B9A8A1FF-4B2D-4BB3-B32A-26DDEC7226AFQ35362654-981E2444-77D6-491A-AE13-B511AC44654CQ35530941-9529C3AC-AF5E-4BFB-B04E-BC86F4C62AFEQ35530965-CC1F1D61-9718-4D30-90F4-D4D5F4B732B9Q35552227-9BB577F3-CB22-4FDD-AC90-514686427139Q35665343-366279FB-737F-4A0B-989B-B20F9A671335Q35689419-F755BDA7-F976-421C-ABCB-84BA3E05B87FQ36125077-E399C6C2-989C-4B47-8E15-FFCCB3031C82Q36147683-987F1079-5AC0-493E-AB4B-26B8D660B7AAQ36672835-C573A7BF-48E0-42FF-9556-78C36F3C3379Q36804257-E629CC1B-941D-4ABE-AD0C-48253417C374
P2860
Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Molecular basis of resistance ...... of lysozyme in staphylococci.
@ast
Molecular basis of resistance ...... of lysozyme in staphylococci.
@en
type
label
Molecular basis of resistance ...... of lysozyme in staphylococci.
@ast
Molecular basis of resistance ...... of lysozyme in staphylococci.
@en
prefLabel
Molecular basis of resistance ...... of lysozyme in staphylococci.
@ast
Molecular basis of resistance ...... of lysozyme in staphylococci.
@en
P2093
P2860
P1433
P1476
Molecular basis of resistance ...... of lysozyme in staphylococci.
@en
P2093
Agnieszka Bera
Ambrose Cheung
Andreas Peschel
Christiane Goerke
Christiane Nerz
Dirk Kraus
Friedrich Götz
Michael Meehl
Silvia Herbert
P2860
P356
10.1371/JOURNAL.PPAT.0030102
P577
2007-07-01T00:00:00Z